The impact of the BIOFIRE® Blood Culture Identification 2 Panel on antimicrobial treatment of children with suspected systemic inflammatory response syndrome and sepsis.

MLA

Devrim, Ilker, et al. “The Impact of the BIOFIRE® Blood Culture Identification 2 Panel on Antimicrobial Treatment of Children with Suspected Systemic Inflammatory Response Syndrome and Sepsis.” European Journal of Pediatrics, vol. 183, no. 3, Mar. 2024, pp. 1353–60. EBSCOhost, https://doi.org/10.1007/s00431-023-05381-7.

APA

Devrim, I., Ayhan, F. Y., Kacar, P., Guner Ozenen, G., Bayram, A., Ergun, D., Ozbakır, H., Gulderen, M., Yilmaz Celebi, M., Ozer, A., Akaslan Kara, A., & Bayram, N. (2024). The impact of the BIOFIRE® Blood Culture Identification 2 Panel on antimicrobial treatment of children with suspected systemic inflammatory response syndrome and sepsis. European Journal of Pediatrics, 183(3), 1353–1360. https://doi.org/10.1007/s00431-023-05381-7

Chicago

Devrim, Ilker, Fahri Yuce Ayhan, Pelin Kacar, Gizem Guner Ozenen, Arzu Bayram, Deniz Ergun, Hincal Ozbakır, et al. 2024. “The Impact of the BIOFIRE® Blood Culture Identification 2 Panel on Antimicrobial Treatment of Children with Suspected Systemic Inflammatory Response Syndrome and Sepsis.” European Journal of Pediatrics 183 (3): 1353–60. doi:10.1007/s00431-023-05381-7.